A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Our company is a targeted healthcare holding company dedicated to acquiring and building middle-market niche healthcare clinics, primarily in orthopedics, spine care, and pain management. Our partnership-driven culture emphasizes service excellence, teamwork, accountability, and performance. We have a geographic specific acquisition strategy driven by targeted merger and acquisition execution across three synergistic complementary pillars: ·Core Cash Flow – Acquiring, optimizing, and managing physician practices to drive recurring revenue and operational efficiency. ·Asset Acquisition – Expanding our footprint through ownership of real estate assets such as ambulatory surgery centers and orthopedic clinics. ·Finance – Retaining and managing personal injury practice accounts receivable to capture long-term income rather than selling at deep discounts, strengthening sustainable profitability.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 12M | 12M | 8.3M | 12M | 11M | 9.9M |
| Net Income | -6.5M | -6.5M | -4.3M | - | - | 666K |
| EPS | $-2.94 | $-2.94 | $-3.27 | $33,723,000.00 | $-224,775,000.00 | $-2,250.00 |
| Free Cash Flow | -2.9M | -2.9M | -2.8M | -1.8M | -1.2M | -854K |
| ROIC | 5.4% | 5.5% | - | - | - | 94.7% |
| Gross Margin | 62.5% | 62.5% | 53.5% | 70.0% | 62.0% | 61.9% |
| Debt/Equity | 0.00 | -7.71 | 5.05 | 6.51 | -1.65 | 2.48 |
| Dividends/Share | $0.01 | $0.01 | $0.02 | - | - | - |
| Operating Income | 1.1M | 1.1M | - | 5.2M | 3.9M | 1.7M |
| Operating Margin | 9.5% | 9.5% | - | 43.8% | 36.5% | 16.8% |
| ROE | 0.0% | -6071.1% | -158.8% | - | - | 91.0% |
| Shares Outstanding | 5M | 5M | 5M | 0M | 0M | 0M |
Cardiff Lexington Corp passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 50.1% with a gross margin of 62.0%. Total shareholder yield (dividends) is 0.6%.
Cardiff Lexington Corp (CDIX) has a 5-year average return on invested capital (ROIC) of 50.1%. This indicates strong capital allocation and a potential competitive advantage.
Cardiff Lexington Corp (CDIX) has a market capitalization of $8M. It is classified as a small-cap stock.
Yes, Cardiff Lexington Corp (CDIX) pays a dividend with a trailing twelve-month yield of 0.60%.
Cardiff Lexington Corp (CDIX) operates in the Services-Offices & Clinics Of Doctors Of Medicine industry, within the Healthcare sector.
Cardiff Lexington Corp (CDIX) reported annual revenue of $12 million in its most recent fiscal year, based on SEC EDGAR filings.
Cardiff Lexington Corp (CDIX) has a net profit margin of -56.7%. The company is currently unprofitable.
Cardiff Lexington Corp (CDIX) generated $-3 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Cardiff Lexington Corp (CDIX) reported earnings per share (EPS) of $-2.94 in its most recent fiscal year.
Cardiff Lexington Corp (CDIX) has a return on equity (ROE) of -6071.1%. A negative ROE may indicate losses or negative equity.
Cardiff Lexington Corp (CDIX) has a 5-year average gross margin of 62.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for Cardiff Lexington Corp (CDIX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Cardiff Lexington Corp (CDIX) has a book value per share of $-0.49, based on its most recent annual SEC filing.
No recent press releases.